Skip to main content
Log in

Analisi socio-economica di lungo periodo di un paziente con una malattia reumatologica rara (CINCA)

  • Published:
PharmacoEconomics Italian Research Articles

Abstract

We present the socio-economic consequences of the chronic infantile neurological cutaneous and articular syndrome (CINCA), one of the various forms of the cryopyrin-associated periodic syndrome (CAPS), through the analysis of the 18 years-long story of one patient. We interviewed the patient and his mother and collected clinical documentation to estimate his life-time costs from the perspectives of the healthcare system and society. Total societal and healthcare costs amount to €178,394 and €137,272, respectively. For about 12 years the patient was not correctly diagnosed; health care costs in this period amounted to €81,280, mainly due to hospital care. After the disease was diagnosed, the pattern of costs dramatically changed with a sharp reduction of hospital costs and an increase of costs for medical therapy. This socioeconomic case-study illustrates the categories of costs that may be associated to patients with rare diseases and suggests that prompter diagnosis and adequate therapies may be also beneficial from a socio-economic perspective.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Bibliografia

  1. Gattorno M, Federici S, Pelagatti MA, et al. Diagnosis and management of autoinflammatory diseases in childhood. J Clin Immunol 2008; 28 Suppl. 1: S73–83

    Article  PubMed  Google Scholar 

  2. Koné-Paut I, Marie I, Piram M, T-A Tran. Cryopyrin-associated syndromes-patient quality of life and psychological impact. European Musculoskeletal Review 2009; 4: 60–2

    Google Scholar 

  3. Neven B, Prieur AM, Quartier dit Maire P, Medscape. Cryopyrinopathies: update on pathogenesis and treatment. Nat Clin Pract Rheumatol 2008; 4: 481–9

    Article  PubMed  CAS  Google Scholar 

  4. Lachmann HJ, Kone-Paut I, Kuemmerle-Deschner JB, et al. Canakinumab in CAPS Study Group. Use of canakinumab in the cryopyrin-associated periodic syndrome. N Engl J Med 2009; 360: 2416–25

    Article  PubMed  CAS  Google Scholar 

  5. Koné-Paut I, Lachmann HJ, Kuemmerle-Deschner JB, et al. Improved health-related quality of life in patients with cryopyrin-associated periodic fever syndrome (CAPS) after treatment with canakinumab (ILARIS) — A fully human anti-IL-1 beta monoclonal antibody. Presented at ACR 2009 (17–21 October), Philadelphia, Pennsylvania, USA. Poster 1482

  6. Kuemmerle-Deschner JB, Hoyer J, Hachulla E, et al. Effect of canakinumab (Ilaris, a fully human anti-IL beta monoclonal antibody) on the health-related quality of life (HRQoL) in cryopyrin-associated periodic syndrome (CAPS) patients. Presented at ACR 2009 (17–21 October), Philadelphia, Pennsylvania, USA. Poster 1483

  7. Ministero dell’Economia e delle Finanze, Commissione Tecnica per la Spesa Pubblica. Libro Verde sulla Spesa Pubblica. Roma, settembre 2007. Disponibile a: http://www.mef.gov.it/doc-finanza-pubblica/documenti/18827/28_libro %20verde.pdf

  8. Conferenza delle Reg on e delle Province Autonome. Tariffa unica convenzionale per le prestazioni di assistenza ospedaliera. Regole e tariffe valide per l’anno 2006. Roma, 15 dicembre 2005

  9. Ministero della Sanità. Prestazioni di assistenza specialistica ambulatoriale erogabili nell’ambito del Servizio Sanitario Nazionale e relative tariffe. Decreto Ministeriale del 22 luglio 1996, pubblicato sul Supplemento Ordinario alla Gazzetta Ufficiale n. 216 del 14 settembre 1996

    Google Scholar 

  10. ISTAT. Lavoro e retribuzioni, anni 2005–2006. Roma, 2008

  11. Associazione Italiana di Economia Sanitaria (AIES). Proposta di linee guida per la valutazione economica degli interventi sanitari in Italia. Pharmacoeconomics-Italian Research Articles 2009; 11: 83–93

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G. Fattore.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fattore, G., Gattorno, M. Analisi socio-economica di lungo periodo di un paziente con una malattia reumatologica rara (CINCA). Pharmacoeconomics-Ital-Res-Articles 12, 157–165 (2010). https://doi.org/10.1007/BF03320673

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03320673

Navigation